Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Cash Flow
Bafna Pharmaceuticals Ltd.
BSE Code 532989
ISIN Demat INE878I01022
Book Value (Rs) 33.57
NSE Code BAFNAPH
Dividend Yield % 0.00
Market Cap(Rs Mn) 2359.72
TTM PE(x) 20.95
TTM EPS(Rs) 4.76
Face Value (Rs) 10  
Type:
(Rs. in Million)
ParticularsMar2020Mar2019Mar2018Mar2017Mar2016
Profit Before Tax-18.83-182.93-147.17-203.63-153.19
Adjustment-194.5254.48-195.26155.02158.36
Changes In working Capital-129.73110.58271.9639.133.94
Cash Flow after changes in Working Capital-343.09-17.87-70.47-9.479.11
Cash Flow from Operating Activities-343.09-17.87-70.47-9.479.11
Cash Flow from Investing Activities327.75153.62379.70-54.20-3.62
Cash Flow from Financing Activities73.01-138.13-306.2963.11-6.05
Net Cash Inflow / Outflow57.68-2.382.93-0.56-0.56
Opening Cash & Cash Equivalents27.1329.5126.5827.1427.70
Cash & Cash Equivalent on Amalgamation / Take over / Merger00000
Cash & Cash Equivalent of Subsidiaries under liquidations00000
Translation adjustment on reserves / op cash balalces frgn subsidiaries00000
Effect of Foreign Exchange Fluctuations00000
Closing Cash & Cash Equivalent84.8127.1329.5126.5827.14